The progress of molecular biology and high-throughput sequencing technology makes EGFR mutation testing in peripheral blood possible.4 On this basis, patients with NSCLC were selected to explore the clinical value of EGFR mutation testing in the peripheral blood of patients with NSCLC. This evidence concerns the gene EGFR and non-small cell lung carcinoma.